DM1-PEG4-DBCO vothyroxine acyl glucuronide Smiles: OC1=CC=CC2[C@H]([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C3=CC(CO)=CC(O)=C3C(=O)C1=2

Smiles: OC1=CC=CC2[C@H]([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C3=CC(CO)=CC(O)=C3C(=O)C1=2

BRD4 FEE-AAA

consecutive telomere dysfunction

InChi: InChI=1S/C9H13N2O2

DM1-PEG4-DBCO vothyroxine acyl glucuronide Smiles: OC1=CC=CC2[C@H]([C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)C3=CC(CO)=CC(O)=C3C(=O)C1=2DM1 (PEG)4 DBCO is a drug linker conjugate composed of a potent microtubulin inhibitor DM1 and a linker DBCO PEG4 Ahx to make antibody drug conjugate (ADC). Mertansine (DM1) is a microtubulin inhibitor and is an antibody conjugatable maytansinoid that is developed to overcome systemic toxicity associated with maytansine and to enhance tumor specific delivery. Product information Molecular Weight: 1198. 79 Formula: C63H80ClN5O16 Chemical Name: [(2R,